166 related articles for article (PubMed ID: 19962477)
1. Optimal management of persistent mixed dyslipidemia after statin initiation warrants combination therapy.
Boden WE; McGovern ME
Am J Cardiol; 2009 Dec; 104(12):1695-6. PubMed ID: 19962477
[No Abstract] [Full Text] [Related]
2. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
Fazio S
Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
[TBL] [Abstract][Full Text] [Related]
3. Statin-fibrate combination therapy.
Feeman WE
Am J Cardiol; 2008 May; 101(10):1521. PubMed ID: 18471475
[No Abstract] [Full Text] [Related]
4. Evaluating optimal lipid levels in patients with mixed dyslipidemia following short- and long-term treatment with fenofibric acid and statin combination therapy: a post hoc analysis.
Mohiuddin SM; Thakker KM; Setze CM; Kelly MT
Curr Med Res Opin; 2011 May; 27(5):1067-78. PubMed ID: 21438793
[TBL] [Abstract][Full Text] [Related]
5. Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia.
Athyros VG; Kakafika AI; Karagiannis A; Mikhailidis DP
Am J Cardiol; 2008 Jun; 101(11):1679-80. PubMed ID: 18489951
[No Abstract] [Full Text] [Related]
6. Treatment of the dyslipidemia of insulin resistance.
Smith DA
Med Clin North Am; 2007 Nov; 91(6):1185-210, x. PubMed ID: 17964916
[TBL] [Abstract][Full Text] [Related]
7. Effects of low-dose of niacin associated to simvastatin in the treatment of mixed dyslipidemia Salgad.
Salgado BJ; Salgado JV; Dos Santos AM; Casulari LA
Minerva Cardioangiol; 2010 Oct; 58(5):531-42. PubMed ID: 20948500
[TBL] [Abstract][Full Text] [Related]
8. Managing the dyslipidemia of metabolic syndrome: beyond statin therapy.
Jialal I; Smith G
Metab Syndr Relat Disord; 2012 Jun; 10(3):159-60. PubMed ID: 22568574
[No Abstract] [Full Text] [Related]
9. Monotherapy vs combination therapy for dyslipidemia in the elderly.
Shepherd J
Am J Geriatr Cardiol; 2008; 17(2):108-13. PubMed ID: 18326949
[TBL] [Abstract][Full Text] [Related]
10. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
Gotto AM; Farmer JA
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
[TBL] [Abstract][Full Text] [Related]
11. Is it necessary to add fibrate to statin therapy in the management of dyslipidemia of metabolic syndrome?
Turhan H; Yetkin E
Int J Cardiol; 2006 Jun; 110(2):276-7. PubMed ID: 16364471
[TBL] [Abstract][Full Text] [Related]
12. Is lipid management effective for all stages of CKD?
Ku E; Campese V
Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
[TBL] [Abstract][Full Text] [Related]
13. Frequency of obtaining national cholesterol education program adult treatment panel III goals for all major serum lipoproteins after initiation of lipid altering therapy.
Nichols GA; Ambegaonkar BM; Sazonov V; Brown JB
Am J Cardiol; 2009 Dec; 104(12):1689-94. PubMed ID: 19962476
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation.
Crespo-Leiro MG; Paniagua MJ; Marzoa R; Grille Z; Naya C; Flores X; Rodriguez JA; Mosquera V; Franco R; Castro-Beiras A
Transplant Proc; 2008 Nov; 40(9):3060-2. PubMed ID: 19010194
[TBL] [Abstract][Full Text] [Related]
15. Clinical inquiries. What are effective medication combinations for dyslipidemia?
Saseen J; Tweed E; Crawford P
J Fam Pract; 2006 Jan; 55(1):70-2. PubMed ID: 16388773
[No Abstract] [Full Text] [Related]
16. A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
Davidson M
Am J Cardiol; 2008 Dec; 102(12A):19L-27L. PubMed ID: 19084086
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic interactions between statins and fibrates.
Corsini A; Bellosta S; Davidson MH
Am J Cardiol; 2005 Nov; 96(9A):44K-49K; discussion 34K-35K. PubMed ID: 16291014
[TBL] [Abstract][Full Text] [Related]
18. Diabetic dyslipidemia: a practical guide to therapy.
Tovar JM; Bazaldua OV; Loffredo A
J Fam Pract; 2008 Jun; 57(6):377-88. PubMed ID: 18544321
[TBL] [Abstract][Full Text] [Related]
19. Colesevelam hydrochloride in the management of dyslipidemia.
Armani A; Toth PP
Expert Rev Cardiovasc Ther; 2006 May; 4(3):283-91. PubMed ID: 16716090
[TBL] [Abstract][Full Text] [Related]
20. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.
Fuentes B; Martínez-Sánchez P; Díez-Tejedor E
Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
